69.39
price up icon2.67%   1.805
 
loading
Precedente Chiudi:
$67.59
Aprire:
$68.07
Volume 24 ore:
331.56K
Relative Volume:
0.50
Capitalizzazione di mercato:
$3.82B
Reddito:
$76.81M
Utile/perdita netta:
$-162.42M
Rapporto P/E:
-23.21
EPS:
-2.99
Flusso di cassa netto:
$-122.49M
1 W Prestazione:
-0.75%
1M Prestazione:
+10.15%
6M Prestazione:
+4.24%
1 anno Prestazione:
+10.93%
Intervallo 1D:
Value
$67.30
$69.75
Intervallo di 1 settimana:
Value
$66.93
$71.58
Portata 52W:
Value
$47.86
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
Nome
Arcellx Inc
Name
Telefono
240-327-0603
Name
Indirizzo
800 BRIDGE PARKWAY, REDWOOD CITY
Name
Dipendente
163
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ACLX's Discussions on Twitter

Confronta ACLX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACLX
Arcellx Inc
69.39 3.85B 76.81M -162.42M -122.49M -2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-17 Iniziato Citigroup Buy
2024-10-08 Iniziato Redburn Atlantic Buy
2024-09-03 Iniziato Cantor Fitzgerald Overweight
2024-05-31 Iniziato Piper Sandler Overweight
2024-03-07 Iniziato Morgan Stanley Overweight
2024-01-04 Reiterato Needham Buy
2023-12-19 Iniziato Scotiabank Sector Outperform
2023-10-30 Iniziato TD Cowen Outperform
2023-10-17 Iniziato UBS Buy
2023-05-18 Iniziato Truist Buy
2023-04-14 Iniziato Robert W. Baird Outperform
2023-03-14 Iniziato Stifel Buy
2023-02-13 Iniziato H.C. Wainwright Buy
2022-12-13 Ripresa BofA Securities Buy
2022-10-31 Iniziato Guggenheim Buy
2022-10-27 Iniziato Needham Buy
2022-07-20 Iniziato Canaccord Genuity Buy
2022-03-01 Iniziato BofA Securities Buy
2022-03-01 Iniziato SVB Leerink Outperform
Mostra tutto

Arcellx Inc Borsa (ACLX) Ultime notizie

pulisher
05:40 AM

Bank of New York Mellon Corp Cuts Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

05:40 AM
pulisher
04:48 AM

What analysts say about Arcellx Inc. stockExceptional risk-adjusted gains - jammulinksnews.com

04:48 AM
pulisher
03:48 AM

What drives Arcellx Inc. stock priceUnrivaled growth potential - jammulinksnews.com

03:48 AM
pulisher
Jul 21, 2025

Principal Financial Group Inc. Sells 184 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Is Arcellx Inc. a good long term investmentFree Stock Market Trend Analysis - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Xponance Inc. Acquires 190 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 20, 2025
pulisher
Jul 17, 2025

There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Price - 富途牛牛

Jul 17, 2025
pulisher
Jul 17, 2025

Arcellx Advances Phase 3 Study for Multiple Myeloma Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Teacher Retirement System of Texas Decreases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 17, 2025
pulisher
Jul 15, 2025

Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Arcellx Inc. stock price move sharplyElite Stock Shortlist - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Arcellx Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

GAMMA Investing LLC Buys 252 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Buys 161 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Allspring Global Investments Holdings LLC Has $468,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

How might ACLX's 2025 Q1 EPS forecast affect strategies? - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Piper Sandler maintains Overweight rating on Arcellx stock amid CAR-T safety study - Investing.com Nigeria

Jul 08, 2025
pulisher
Jun 30, 2025

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Benzinga

Jun 30, 2025
pulisher
Jun 23, 2025

(ACLX) Trading Signals - news.stocktradersdaily.com

Jun 23, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Cancer Cell Market Exclusive Report with Detailed Study Analysis | Abbott Laboratories, Cellectis, Arcellx, GE - newstrail.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citigroup Initiates Arcellx at Buy With $110 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx (ACLX): Citi Initiates Buy Rating with Promising Outlook | ACLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Aileen Fernandes | People on The MoveSan Francisco Business Times - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Aileen Fernandes - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito-cel: A Promising Market Entrant with Superior Efficacy and Safety in Multiple Myeloma Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito Cel Therapy: A Promising Contender in Multiple Myeloma Treatment with Strong Market Potential - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

ACLX: HC Wainwright & Co. Reiterates Buy Rating with $115 Target | ACLX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx stock maintains buy rating at H.C. Wainwright on launch plans - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Strategic Partnership with Kite Enhances Anito-cel Therapy Launch and Market Position - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Positive Outlook for Arcellx Inc: Promising Anito-cel Therapy and Strategic Market Positioning - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Promising Market Position and Growth Potential in Multiple Myeloma Therapy - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Transcript : Arcellx, Inc.Special Call - MarketScreener

Jun 13, 2025
pulisher
Jun 12, 2025

(ACLX) Technical Data - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Arcellx’s SWOT analysis: CAR-T pioneer’s stock poised for myeloma market shake-up - Investing.com

Jun 12, 2025

Arcellx Inc Azioni (ACLX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):